Customize your JAMA Network experience by selecting one or more topics from the list below.
Cooper GS, Kou TD, Rex DK. Complications Following Colonoscopy With Anesthesia AssistanceA Population-Based Analysis. JAMA Intern Med. 2013;173(7):551–556. doi:10.1001/jamainternmed.2013.2908
Importance Deep sedation for endoscopic procedures has become an increasingly used option but, because of impairment in patient response, this technique also has the potential for a greater likelihood of adverse events. The incidence of these complications has not been well studied at a population level.
Design Population-based study.
Setting and Participants Using a 5% random sample of cancer-free Medicare beneficiaries who resided in one of the regions served by a SEER (Surveillance, Epidemiology, and End Results) registry, we identified all procedural claims for outpatient colonoscopy without polypectomy from January 1, 2000, through November 30, 2009.
Intervention Colonoscopy without polypectomy, with or without the use of deep sedation (identified by a concurrent claim for anesthesia services).
Main Outcome Measures The occurrence of hospitalizations for splenic rupture or trauma, colonic perforation, and aspiration pneumonia within 30 days of the colonoscopy.
Results We identified a total of 165 527 procedures in 100 359 patients, including 35 128 procedures with anesthesia services (21.2%). Selected postprocedure complications were documented after 284 procedures (0.17%) and included aspiration (n = 173), perforation (n = 101), and splenic injury (n = 12). (Some patients had >1 complication.) Overall complications were more common in cases with anesthesia assistance (0.22% [95% CI, 0.18%-0.27%]) than in others (0.16% [0.14%-0.18%]) (P < .001), as was aspiration (0.14% [0.11%-0.18%] vs 0.10% [0.08%-0.12%], respectively; P = .02). Frequencies of perforation and splenic injury were statistically similar. Other predictors of complications included age greater than 70 years, increasing comorbidity, and performance of the procedure in a hospital setting. In multivariate analysis, use of anesthesia services was associated with an increased complication risk (odds ratio, 1.46 [95% CI, 1.09-1.94]).
Conclusions and Relevance Although the absolute risk of complications is low, the use of anesthesia services for colonoscopy is associated with a somewhat higher frequency of complications, specifically, aspiration pneumonia. The differences may result in part from uncontrolled confounding, but they may also reflect the impairment of normal patient responses with the use of deep sedation.
Colonoscopy is currently one of the recommended screening modalities for the prevention of colorectal cancer.1,2 Colonoscopy procedures traditionally have been performed with conscious sedation, which involves the administration of a benzodiazepine and a narcotic. However, within the past decade, there has been increasing use of propofol, a sedative agent with no analgesic properties. Although a precedent exists for both nonanesthesiologist administration of propofol and nurse-administered propofol sedation,3,4 because of its narrow therapeutic window with the potential for apnea, propofol typically has been administered by anesthesiology personnel.
Studies that have included physician surveys5 and health claims data6-9 have documented an increasing use of propofol and/or anesthesiology services in colonoscopy practice. These studies have reported a marked rise in the use of anesthesiology assistance over time, increasing from 11% in 2000 to 23.4% in 2006 in a Medicare cohort7 and from 13.6% in 2003 to 35.5% in 2009 in commercially insured individuals.8
Despite the known advantages of propofol use, population-based studies have not considered the potential adverse events associated with administration. Specifically, compared with conscious sedation, deep sedation would be expected to blunt patient responses to painful stimuli. Thus, a potentially higher risk of traumatic injuries during colonoscopy exists, including perforation and splenic injury. Because of diminished airway protective reflexes associated with deep sedation, a potentially higher risk of aspiration at the time of the procedure also exists. However, to our knowledge, the frequency of these complications has not been compared with conscious sedation at a population level.
We therefore conducted the present study in a large population-based sample of Medicare beneficiaries undergoing outpatient colonoscopy. To minimize confounding by procedural interventions, such as polypectomy, the study was limited to diagnostic colonoscopies. We hypothesized that, although infrequent, the potential risk of sedation-associated adverse events would be higher with the use of deep sedation.
The data for the study were obtained from a noncancer sample of the linked SEER (Surveillance, Epidemiology, and End Results) Program–Medicare database.10,11 The files consist of a 5% random sample of Medicare beneficiaries without cancer who reside in one of the geographic areas contained in the SEER registries. The SEER Program currently captures approximately 26% of the US population.
Medicare claims are contained in 3 different files: the Carrier file, which includes provider claims; the Outpatient file, which includes claims from institutional outpatient providers; and the Medicare Provider Analysis and Review (MEDPAR) file, which includes all hospitalizations. Each Medicare claim contains diagnoses coded by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and procedures coded according to the fourth edition of Common Procedural Terminology (CPT-4)12 or the ICD-9-CM. In addition to Medicare claims, the Summarized Denominator (SUMDENOM) file contains demographic, enrollment, and entitlement information for all patients in the database.
The cohort of patients undergoing outpatient diagnostic colonoscopy was identified using the January 1, 2000, through November 30, 2009, Medicare Carrier and Outpatient files. Patients were eligible if they were 66 years or older (to allow measurement of comorbidities during the year prior to the colonoscopy procedure) and were receiving Medicare benefits through Part A and Part B for at least 1 year prior to and 30 days after the colonoscopy. Patients who were enrolled in Medicare-sponsored managed care plans during the 1-year period prior to and 30-day period after the colonoscopy were also excluded because of the high likelihood of incomplete claims.
All claims for diagnostic colonoscopy were identified by procedure codes (CPT-4 codes 44388, 44389, 45378, 45380, G0105, and G0121 and ICD-9-CM codes 45.23 and 45.25). These codes were selected to minimize the likelihood that procedural interventions, such as snare polypectomy or control of hemorrhage, would independently increase the risk of traumatic injury. Patients were monitored from the index colonoscopy for up to 30 days after the procedure for the occurrence of specific complications and up to 1 year for death.
Consistent with previous studies,6-8 we identified anesthesiology involvement with colonoscopy by the CPT-4 code 00810, anesthesia assistance with endoscopic procedure distal to the duodenum, occurring on the same date as the colonoscopy of interest. Although this approach does not specifically identify the use of propofol, it is presumed that most anesthesia-assisted procedures would include this agent.
Demographic characteristics, including age, sex, and race, were obtained from the SUMDENOM file. Diagnosis codes according to ICD-9-CM during the 365-day to 30-day interval (total, 11 months) prior to the index colonoscopy were searched to derive a previously validated, weighted comorbidity index.13 We also searched the claims from 1 year before the procedure for a diagnosis of obstructive sleep apnea (ICD-9-CM codes 780.51, 780.53, and 780.57).
We characterized the type of facility in which the colonoscopy was performed as a hospital, an ambulatory surgery center, or other/unknown. Geographic regions were divided into Northeast, South, Midwest, Southwest, and West.
The major outcome of interest was the occurrence of 1 or more prespecified complications requiring hospitalization within 30 days of the colonoscopy. The MEDPAR and Carrier files were searched for the following codes: aspiration pneumonia (ICD-9-CM codes 507.0 and 507.8), colonic perforation (ICD-9-CM codes 540.0, 540.1, 569.49, and 569.83), and splenic injury/rupture (ICD-9-CM codes 865.04 and 865.14) or splenectomy (ICD-9-CM code 41.5 and CPT-4 codes 38100, 38101, and 38115).
In the initial analysis, we identified patient and provider characteristics associated with the use of anesthesia services. The frequencies across subgroups were compared using χ2 analysis.
The major outcome of interest was the occurrence of the specific complications within 30 days of the index procedure. The frequency of procedural complications was calculated by dividing the number of procedures with a complication by the number of total procedures. We also identified patient, facility, and geographic factors associated with the occurrence of complications and compared the frequencies with χ2 analysis. Because of the small numbers of individual complications and per National Cancer Institute and Centers for Medicare & Medicaid Services data security policy, specific subtypes of complications were not analyzed separately. In addition, multivariate logistic regression was used to determine the independent association of anesthesiology services and complication risk. We tested selected interaction terms in the model (age, comorbidity, and anesthesiology services) but, because they did not achieve statistical significance, they were not included in the final analysis.
To determine the robustness of our findings, we performed 2 additional analyses. The first was an analysis performed among patients undergoing colonoscopy at ambulatory surgery centers, recognizing that such patients may have lower severity of illness than those treated in an outpatient hospital setting. The second was a multivariate logistic regression analysis that included an instrumental variable consisting of the proportion of eligible patients undergoing procedures with anesthesia assistance in their specific SEER registry.14
From the database, we identified a total of 165 527 examinations in 100 359 patients who met the entry and exclusion criteria. This included 130 399 colonoscopies (78.8%) performed without anesthesia assistance and 35 128 (21.2%) with anesthesia assistance. Demographics of the patient population and associations with anesthesia assistance are shown in Table 1. The mean (SD) age of the sample was 75.5 (6.4) years, 55.0% were female, and 85.1% were white. Most patients had comorbidity scores of 0 or 1, and only 2.9% had a previous diagnosis of sleep apnea. Almost 30% of the colonoscopies were performed in an ambulatory surgery center, and the largest numbers were performed in the Western and Northeastern United States.
Factors associated with anesthesia services were identified (Table 1). Anesthesia was more commonly used in African Americans compared with whites and other racial groups. Anesthesia was also more likely to be included in procedures that were performed in ambulatory surgery centers. We also observed significant geographic variation, with more than 40% of procedures in the Northeastern United States including anesthesia services compared to 9% or less in the Southwest or West. The proportion of colonoscopies with anesthesia also increased from 8.6% in 2000 to 35.4% in 2009. The overall 30-day mortality was 0.29% and was similar in the anesthesia (0.32%) and nonanesthesia (0.28%) groups (P = .29). The overall 1-year mortality was 2.68% and was similar in the anesthesia (2.82%) and nonanesthesia (2.64%) groups (P = .06).
In the cohort, aspiration, perforation, and splenic injury were the complications recorded in 284 cases (0.17%), with 205 (0.16%; 95% CI, 0.14%-0.18%) in the nonanesthesia group compared with 79 (0.22%; 0.18%-0.27%) in the anesthesia group (P < .001). The most frequent complication was aspiration (n = 173), with greater frequency in the anesthesia group (0.14%; 95% CI, 0.11%-0.18%) than in the nonanesthesia group (0.10%; 0.08%-0.12%; P = .02). The incidence of perforation (n = 101) and splenic injury (n = 12) was statistically similar between groups. Other risk factors for postprocedure complications are shown in Table 2 and included older age, male sex, increased comorbidity, and hospital-based procedures. These differences were also observed in multivariate analysis. For anesthesia services, the multivariate odds ratio (OR) for occurrence of complications was 1.46 (95% CI, 1.09-1.94).
In a secondary analysis of procedures performed in an ambulatory surgery center as opposed to a hospital outpatient setting, there were fewer total complications (n = 46), with 29 in the nonanesthesia group (0.08%) and 17 in the anesthesia group (0.14%). However, because of the smaller frequency of adverse events, the differences did not achieve statistical significance in unadjusted (P = .11) or multivariate logistic regression (OR, 1.67; 95% CI, 0.83-3.33) analysis. We also performed an analysis in which the proportion of colonoscopies in a given SEER region was included as an instrumental variable. The results were consistent with the primary analysis (multivariate OR, 1.35 for anesthesia assistance; 95% CI, 1.01-1.81)
In recent years, administration of propofol for the performance of colonoscopy has increased.7,8 Whereas patients with complex medical problems and a known intolerance to conscious sedation are probably more appropriate for anesthesia involvement in procedures,much of the observed variation in the use of anesthesia presumably relates to physician discretion. In patients without clear medical indications for deep sedation, the potential advantages of propofol include the rapid onset of sedation, faster recovery time, and improved patient and provider satisfaction. The major disadvantage cited is the greater financial cost to the patient and health care system, which is approximately 20% higher than costs without anesthesia assistance.7,8
In this analysis, which included a large population-based sample of colonoscopies, we report a somewhat higher complication risk with anesthesia involvement. Although the absolute incidence of postprocedure complications was very low, we found an almost 50% increased adjusted risk in procedures that were associated with anesthesia services. Based on the estimated number of colonoscopies in the entire Medicare population in 2009, this difference of 0.06% would extrapolate to a net annual increase of 518 (95% CI, 432-604) complications.
We identified and studied 3 complications that we consider potentially increased in patients undergoing deeper levels of sedation. Splenic injury has been described in multiple case reports, with the most recent estimate of 93 reported cases from the mid-1970s through 2011.15 With the exception of a case series in which 6 of 9 patients received propofol,16 the type of sedation has not been previously described as a risk factor. Presumably, deeper levels of sedation could allow creation of complex loops in the colonoscope, which might not be tolerated by patients with moderate levels of sedation and which may stress the attachments between the spleen and colon. In a related potential mechanism, the use of deep sedation might prevent the patient from expressing pain associated with stress on splenic-colonic attachments that would serve as a warning to the endoscopist to change insertion tactics. However, we did not demonstrate a statistically significant increase in splenic injury in patients undergoing deep sedation.
The incidence of perforation in large samples has ranged from 0.19 to 0.9 per 1000 colonoscopies17-19 and was typically increased with the use of polypectomy. In 2 of the studies, the type of sedation was not examined separately18,19; in a report that included data from an endoscopic registry, it was not predictive.17 However, in the latter study, propofol was administered in only 1.3% of procedures. As with splenic injury, we hypothesize that deep sedation may predispose to this complication if colonoscopists continue to push the instrument forward when fixed resistance is palpated and the patient is unable to perceive pain that would warn the endoscopist to stop insertion. Analogous to splenic injury, however, we did not demonstrate a statistically increased risk of perforation in diagnostic colonoscopies.
Aspiration is a relatively underrecognized complication of endoscopic procedures but may be more frequent than perforation.20 In a large series of patients receiving monitored anesthesia care,21 most of whom received propofol, aspiration occurred in 5 of 3155 colonoscopies (0.16%) and in 0.10% of all procedures. In a recently published study that used coughing during procedures as a surrogate measure of microaspiration, the use of propofol for sedation was associated with an increased risk of cough.21 We found that anesthesia services were associated with an increased risk of aspiration, and an increased risk of aspiration was the main factor accounting for the overall increase in the complications we identified in patients undergoing colonoscopy with anesthesia services.
We recognize several potential limitations of the study. First, because the study was a nonrandomized observational study, we could not completely adjust for potential differences in case mix between the anesthesia and nonanesthesia groups. Because of potential selection bias in the choice of sedation, the increased complication rate associated with anesthesia assistance may have resulted from comorbidity. However, we attempted to minimize this potential bias by performing a secondary analysis using instrumental variables and in patients treated only in ambulatory surgical centers, and the results were consistent. Second, as in previous analyses,6-8 we used claims for anesthesia services as a proxy for propofol administration. Although we could not obtain medical records to verify what medications a patient received, one can assume that the overwhelming majority received propofol. Because our study design required hospitalization for a postprocedure complication, another potential limitation is underascertainment of complications. However, we anticipate that the overwhelming majority of the type of complications included in the study would have resulted in use of the health care system. We also could not validate the occurrence of the complication and whether the complication directly resulted from the procedure. Finally, despite the large total sample size, the number of patients with individual complications was low; thus, the power to identify risk factors for specific complications was limited.
In summary, in this large sample of Medicare beneficiaries, we identified the use of anesthesiology services for colonoscopy as one of the risk factors for complications, specifically aspiration pneumonia. The absolute risk for these complications was low in colonoscopies with as well as those without anesthesiologist involvement, and differences may have resulted in part from uncontrolled confounding based on patient severity. Nonetheless, the depth of sedation may serve as an independent risk factor for adverse outcomes.
Correspondence: Gregory S. Cooper, MD, Division of Gastroenterology, University Hospitals Case Medical Center, 11100 Euclid Ave, Cleveland, OH 44106 (email@example.com).
Accepted for Publication: October 28, 2012.
Published Online: March 11, 2013. doi:10.1001/jamainternmed.2013.2908
Author Contributions: Drs Cooper and Kou had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Cooper, Kou, and Rex. Acquisition of data: Cooper. Analysis and interpretation of data: Cooper, Kou, and Rex. Drafting of the manuscript: Cooper. Critical revision of the manuscript for important intellectual content: Cooper, Kou, and Rex. Statistical analysis: Kou. Obtained funding: Cooper.
Conflict of Interest Disclosures: None reported.
Funding Support: This study was supported in part by grants R01 CA132862 from the National Cancer Institute at the National Institutes of Health and UL1TR000439 from the National Center for Advancing Translational Sciences at the National Institutes of Health.
Disclaimer: This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors.
Additional Contributions: We acknowledge the efforts of the Applied Research Program, National Cancer Institute; the Office of Research, Development, and Information, Centers for Medicare and Medicaid Services; Information Management Services, Inc; and the SEER Program tumor registries in the creation of the SEER-Medicare database.
Create a personal account or sign in to: